Skip to main content
. Author manuscript; available in PMC: 2022 Aug 20.
Published in final edited form as: Alzheimers Dement. 2021 Dec 2;18(8):1523–1536. doi: 10.1002/alz.12508

TABLE 2.

Multinomial model contrasting the normal control group versus each of the other groups (N = 569)

NC vs. β z COR 95% CI Wald Z P
(Intercept) MCI 0.067 1.07 (0.06, 17.27) 0.047 0.962
AD dementia 1.811 6.12 (0.16, 205.35) 1.115 0.265
P-tau181 MCI 0.126 1.13 (0.89, 1.44) 1.015 0.310
AD dementia 0.385 1.47 (1.06, 2.08) 2.650 0.008**
T-tau MCI 0.056 1.06 (0.83, 1.35) 0.491 0.624
AD dementia 0.184 1.20 (0.91, 1.58) 1.402 0.161
NfL MCI 0.220 1.25 (0.93, 1.67) 1.578 0.115
AD dementia 0.929 2.53 (1.71, 3.65) 5.573 <0.001***
Age MCI 0.024 1.02 (0.99, 1.06) 1.491 0.136
AD dementia 0.018 1.02 (0.98, 1.06) 0.979 0.327
Race MCI 1.067 2.91 (1.51, 5.52) 3.578 <0.001***
AD dementia −0.300 0.74 (0.27, 1.83) −0.696 0.487
Sex MCI −0.394 0.67 (0.43, 1.05) −1.809 0.070
AD dementia −1.072 0.34 (0.21, 0.59) −4.171 <0.001***
Years of education MCI −0.124 0.88 (0.82, 0.96) −3.060 0.002**
AD dementia −0.232 0.79 (0.72, 0.88) −4.897 <0.001***
APOE ε4 allele status MCI 0.037 1.04 (0.67, 1.64) 0.162 0.871
AD dementia 1.125 3.08 (1.80, 5.12) 4.394 <0.001***

Abbreviations: AD, Alzheimer’s disease; APOE, apolipoprotein E; CI, confidence interval; COR, conditional odds ratio; MCI, mild cognitive impairment; NC, normal control; NfL, neurofilament light; P-tau181, hyperphosphorylated tau; T-tau, Total tau.